Research Reports

  • 30 March 2017

    A serious threat on the horizon for Imbruvica

    AbbVie and Janssen, who co-market Imbruvica, can expect to enjoy strong Imbruvica sales for a few years to come; however, GlobalData has identified a significant threat not too far off...

Close
Close
Close

Go Top